Identification and functional characterization of potential oncofetal targets in human hepatocellular carcinoma

por Li, Mei-Mei, Kong, Fan-En, Li, Guang-Meng, He, Yi-Ti, Zhang, Xiao-Feng, Zhang, Cheng-Yang, Liang, Jie-Kai, Guan, Xin-Yuan, Ma, Ning-Fang, Xie, Mao-Bin, Liu, Ming
Publicado 2022

Development of an oncogenic dedifferentiation SOX signature with prognostic significance in hepatocellular carcinoma

por Li, Mei-Mei, Tang, Yun-Qiang, Gong, Yuan-Feng, Cheng, Wei, Li, Hao-Long, Kong, Fan-En, Zhu, Wen-Jie, Liu, Shan-Shan, Huang, Li, Guan, Xin-Yuan, Ma, Ning-Fang, Liu, Ming
Publicado 2019

PARP inhibitor Olaparib overcomes Sorafenib resistance through reshaping the pluripotent transcriptome in hepatocellular carcinoma

por Yang, Xiao-Dong, Kong, Fan-En, Qi, Ling, Lin, Jia-Xin, Yan, Qian, Loong, Jane Ho Chun, Xi, Shao-Yan, Zhao, Yue, Zhang, Yan, Yuan, Yun-Fei, Ma, Ning-Fang, Ma, Stephanie, Guan, Xin-Yuan, Liu, Ming
Publicado 2021

Growth differentiation factor 1-induced tumour plasticity provides a therapeutic window for immunotherapy in hepatocellular carcinoma

por Cheng, Wei, Li, Hao-Long, Xi, Shao-Yan, Zhang, Xiao-Feng, Zhu, Yun, Le Xing, Mo, Yan-Xuan, Li, Mei-Mei, Kong, Fan-En, Zhu, Wen-Jie, Chen, Xiao-Gang, Cui, Hui-Qing, Cao, Zhi-Ming, Gong, Yuan-Feng, Tang, Yun-Qiang, Zhang, Yan, Guan, Xin-Yuan, Ma, Ning-Fang, Liu, Ming
Publicado 2021